Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Processes × ficlatuzumab × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasm Metastasis 1 Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 2 Pemetrexed 1 MRX-2843 1 Control Groups 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡